ION Exchange (India) Limited — Investor Meet, 17-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Ion Exchange revamped its reporting, splitting Engineering into Treatment Solutions, Industrial Products, and Lifecycle Services, and renaming Chemicals to Specialty Chemicals for enhanced transparency. Q1 FY'27 operating income rose 20% to INR 701 Cr, but EBITDA fell 49% to INR 32 Cr, with PAT at INR 3 Cr. Profitability was notably impacted by legacy projects and initial costs from the new Roha plant. The company holds a strong order book of INR 2,473 Cr, alongside a new INR 431.6 Cr Hyundai contract. Management acknowledged Q1 challenges but expressed optimism, focusing on improved execution, scaling new capacities (resins, membranes), and targeting high-tech areas like semiconductors and green hydrogen for long-term profitable growth.